Haukeland University Hospital is a hospital in Bergen, Norway, and one of the eleven institutions that make up Bergen Hospital Trust.

There are 1,100 beds in Haukeland University Hospital.

During the past decade, Haukeland University Hospital conducted 208 clinical trials. In the 10-year time frame, 208 clinical trials started and 14 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 101 clinical trials started and 10 clinical trials were completed. i.e. 9.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Haukeland University Hospital" #1 sponsor was "Haukeland University Hospital" with 132 trials, followed by "Oslo University Hospital" with 22 trials sponsored, "University of Bergen" with 21 trials sponsored, "Helse Stavanger HF" with 8 trials sponsored and "Norwegian University of Science and Technology" with 8 trials sponsored. Other sponsors include 123 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Haukeland University Hospital" #1 collaborator was "Haukeland University Hospital" with 66 trials as a collaborator, "University of Bergen" with 36 trials as a collaborator, "University Hospital of North Norway" with 33 trials as a collaborator, "St. Olavs Hospital" with 29 trials as a collaborator and "Helse Stavanger HF" with 25 trials as a collaborator. Other collaborators include 495 different institutions and companies that were collaborators in the rest 274 trials.

According to Clinical.Site data, the most researched conditions in "Haukeland University Hospital" are "Ischemic Stroke" (5 trials), "Multiple Myeloma" (5 trials), "Obesity" (5 trials), "Amyotrophic Lateral Sclerosis" (4 trials) and "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Haukeland University Hospital" in a lesser frequency.

Most popular intervention types in "Haukeland University Hospital" are "Drug" (118 trials), "Other" (55 trials), "Procedure" (46 trials), "Device" (24 trials) and "Dietary Supplement" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "placebo" (6 trials), "Nicotinamide Riboside" (5 trials), "Bevacizumab" (4 trials) and "Oxaliplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Haukeland University Hospital" are 288 trials for "All" genders, 20 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 139 active trials in "Haukeland University Hospital". 1 are not yet recruiting, 94 are recruiting, 41 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 128 completed trials in Haukeland University Hospital, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Haukeland University Hospital, 20 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 112 trials that are defined as “Not Applicable".